Socié, Gérard <br/><br/>
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD.  [electronic resource] 

 -  Blood  02 2017 
 - 643-649 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2016-09-738625  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antilymphocyte Serum--adverse effects<br/>Drug Resistance<br/>Female<br/>Graft vs Host Disease--drug therapy<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Steroids--therapeutic use<br/>Survival Analysis<br/>Treatment Outcome